These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 11273071

  • 21. [Ticlopidine and bone marrow aplasia].
    Sánchez Ayuso J, Fernández González F, Fernández Rodríguez E.
    Med Clin (Barc); 1997 Nov 08; 109(16):649. PubMed ID: 9463147
    [No Abstract] [Full Text] [Related]

  • 22. Ticlopidine-associated aplastic anemia. A case report and review of literature.
    Yeh SP, Hsueh EJ, Wu H, Wang YC.
    Ann Hematol; 1998 Feb 08; 76(2):87-90. PubMed ID: 9540764
    [Abstract] [Full Text] [Related]

  • 23. Bioequivalence in the real world is a complex challenge: the case of clopidogrel.
    Marcucci R, Paniccia R, Gori AM, Gensini GF, Abbate R.
    J Am Coll Cardiol; 2013 Feb 05; 61(5):594-5. PubMed ID: 23246390
    [No Abstract] [Full Text] [Related]

  • 24. Reversible ageusia associated with clopidogrel treatment.
    Koc F, Ozeren A.
    Neurol India; 2006 Jun 05; 54(2):218-9. PubMed ID: 16804280
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients.
    David JL, Limet R.
    Thromb Haemost; 1999 Nov 05; 82(5):1417-21. PubMed ID: 10595630
    [Abstract] [Full Text] [Related]

  • 28. Antithrombotic therapy after coronary-artery stenting.
    Ferrer F, Moraleda JM, Vicente V.
    N Engl J Med; 1999 Apr 29; 340(17):1365; author reply 1367. PubMed ID: 10223873
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A randomized, double-blind study comparing the safety and efficacy of clopidogrel versus ticlopidine in Japanese patients with noncardioembolic cerebral infarction.
    Fukuuchi Y, Tohgi H, Okudera T, Ikeda Y, Miyanaga Y, Uchiyama S, Hirano M, Shinohara Y, Matsumoto M, Yamaguchi T.
    Cerebrovasc Dis; 2008 Apr 29; 25(1-2):40-9. PubMed ID: 18033957
    [Abstract] [Full Text] [Related]

  • 31. Clopidogrel and proton pump inhibitor use: what does the evidence really say?
    Baker WL, Coleman CI, Lundbye JB.
    Conn Med; 2010 Jan 29; 74(1):27-31. PubMed ID: 20175370
    [No Abstract] [Full Text] [Related]

  • 32. Agranulocytosis associated with ticlopidine: a possible benefit with filgastim.
    Marinella MA.
    Ann Clin Lab Sci; 1997 Jan 29; 27(6):418-21. PubMed ID: 9433539
    [Abstract] [Full Text] [Related]

  • 33. [Treatment of ischemic heart disease with the platelet aggregation inhibitor clopidogrel].
    Helø OH, Madsen JK, Kastrup J.
    Ugeskr Laeger; 2004 Apr 26; 166(18):1659-62. PubMed ID: 15174400
    [No Abstract] [Full Text] [Related]

  • 34. Non-bleeding side effects of clopidogrel: have large multi-center clinical trials underestimated their incidence?
    Almsherqi ZA, McLachlan CS, Sharef SM.
    Int J Cardiol; 2007 May 02; 117(3):415-7. PubMed ID: 16919820
    [Abstract] [Full Text] [Related]

  • 35. Clopidogrel-Induced Auditory and Visual Hallucinations.
    Osuagwu FC, Parashar S, Amalraj B, Tinklepaugh M, Dillon J, Bradley RH.
    Prim Care Companion CNS Disord; 2016 May 02; 18(3):. PubMed ID: 27722029
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Ticlopidine-induced aplastic anemia: development of chromosomal abnormalities and response to immunosuppressive therapy.
    Pullarkat VA, Rho H, Murata-Collins JL, Liebman HA.
    Am J Hematol; 2000 Mar 02; 63(3):141-4. PubMed ID: 10679804
    [Abstract] [Full Text] [Related]

  • 38. The CAPRIE trial: culmination of the preregistration program for clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events. Clopidogrel versus aspirin in patients at risk of ischaemic events.
    Gent M.
    Semin Thromb Hemost; 1999 Mar 02; 25 Suppl 2():1-2. PubMed ID: 10440414
    [No Abstract] [Full Text] [Related]

  • 39. Clopidogrel: secondary prevention of vascular ischaemic events.
    Misson J, Clark W, Kendall MJ.
    J Clin Pharm Ther; 1998 Apr 02; 23(2):91-5. PubMed ID: 9786094
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.